Institutional Investment Pitches
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Going back to MOBI, we believe the company is poised to capitalize on a multibillion-dollar market opportunity using its Vagus Nerve Stimulator (Vivistim) to enhance stroke recovery for patients who have recently experienced a stroke (incidence), as well as patients who have had a stroke any time over the past 20+ years (prevalence). When Vivistim is...
— Tom Wetherald and Eddie Reilly
Full equity research memos, financial breakdowns, and hedge fund thesis write-ups are reserved for BSD Research ($50/mo) and Pro subscribers.
Already a Research or Pro subscriber? Sign In
Other investors who've written on Mobia Medical
No other institutional pitches found for this ticker yet.
More institutional theses from Minot Light Capital Partners
Suja Life produces and markets organic, cold-pressed juices and functional wellness shots under the Suja and Vive brands. The manager maintains...
Stran & Company provides outsourced promotional marketing, branded merchandise, and technology-driven corporate branding solutions, and currently represents a top-10 holding in the portfolio. Minot Light maintains...
Hayward Holdings designs, manufactures, and markets residential and commercial pool equipment and systems. The manager maintains...